Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | BMC Cancer

Figure 4

From: Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast

Figure 4

Hazard rate estimates for distant metastasis by metastatic site in 1528 ERP tumours (A) and in 391 ERN tumours (B) from patients undergoing conservative surgery (quadrantectomy or tumourectomy) plus RT. The similarity of recurrence dynamics provides evidence that recurrence timing is generated by factors influencing the metastatic development, regardless of the seeded organ. Vertical lines represent point-wise confidence interval for the model estimated hazards, according to standard asymptotic theory.

Back to article page